Cotrimoxazole Prophylaxis Selects for Antimicrobial Resistance in Human Immunodeficiency Virus-Exposed, Uninfected Infants
- PMID: 31832637
- PMCID: PMC7778347
- DOI: 10.1093/cid/ciz1193
Cotrimoxazole Prophylaxis Selects for Antimicrobial Resistance in Human Immunodeficiency Virus-Exposed, Uninfected Infants
Keywords: HIV-exposed uninfected; antibiotics; antimicrobial resistance; cotrimoxazole; infants; microbiome.
Comment on
-
Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus-Exposed, Uninfected Infants.Clin Infect Dis. 2020 Dec 31;71(11):2858-2868. doi: 10.1093/cid/ciz1186. Clin Infect Dis. 2020. PMID: 31832638 Free PMC article.
References
-
- Joint United Nations Programme on HIV/AIDS. AIDSInfo: elimination of mother-to-child transmission Available at: http://aidsinfo.unaids.org/. Accessed 20 November 2019.
-
- Brennan AT, Bonawitz R, Gill CJ, et al. A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children. AIDS 2016; 30:2351–60. - PubMed
-
- Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis 2016; 16:e92–107. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
